Dr. Burd is very excited about his latest Patent and stated “Lysulin is the only product that targets the cause of insulin resistance and diabetes. Clinical studies have shown that people using Lysulin have improved insulin resistance and beta cell function. This patent will prevent potential competitors from using our discovery while we help people with diabetes and Prediabetes to better health.”
This patent is about “A method of improving insulin resistance by using a supplement may include: Lysine, Zinc and Vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample”.
Dr. John F. Burd, Ph.D., CEO of Lysulin and the original Founder of Dexcom, was granted a Patent that supports his 30 years of study in the field of Diabetes and helping people of all ages manage their A1c levels naturally without prescription medications.
This patent is about "A method of improving insulin resistance by using a supplement may include: Lysine, Zinc and Vitamin C to a user; monitoring an insulin resistance level before and after the supplement is administered in a bio-sample; and determining a change in a dose of the supplement based on the insulin resistance level found in the bio-sample".
The patent details can be viewed at https://lysulin.com/patents/US-10610544B2.pdf
Dr. Burd was very excited about the Patent and stated that "Lysulin is the only product that targets the cause of insulin resistance and diabetes. Clinical studies have shown that people using Lysulin have improved insulin resistance and beta cell function. This patent will prevent potential competitors from using our discovery while we help people with diabetes and Prediabetes to better health."
Dr. Burd's company, Lysulin.com was founded in 2017 to help diabetics and prediabetics with its unique combination of Lysine, Zinc and Vitamin C. In addition to his breakthrough nutritional supplement, Lysulin has created a public Diabetes Wellness Community of more than 60,000 followers on Facebook that enables consumers to engage and socialize with other diabetics, prediabetics and diabetes care-givers to learn lifeskills, tips and techniques to live a better life in spite of diabetes.
Diabetes can increase the risk of many serious health problems. That’s because when glucose accumulates in the blood, it attaches to protein and makes it dangerous to other parts of the body like the heart, kidneys, blood vessels and eyes. Glucose doesn’t have to bind to protein if there is something else it can attach to. That’s where Lysulin comes in.
This patent validates Lysulin, as it attaches to glucose so it can be safely excreted from the body to help maintain healthy levels of A1c blood sugar levels in diabetics and prediabetics. It’s natural and is proven to work in a human clinical study.
In addition to this very important patent, Dr. Burd also received three additional patents this year that support his research and solutions for the global pandemic known as Diabetes. Those three patents can be found on the Lysulin.com website at:
Prevention of Protein Glycation Using Lysine/Zinc Supplements
https://lysulin.com/patents/US-10653720.pdf
Inhibiting Chronic Blood and Nephrological Disorders Using Lysine-Based Supplements
https://lysulin.com/patents/US-10656166.pdf
Prevention of Protein Glycation Using Lysine Supplements
https://lysulin.com/patents/US-10695368.pdf
Persons interested in learning more about Dr. Burd or Lysulin can visit his personal website at https://jburd.com and business website at https://Lysulin.com
